Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its position in CME Group Inc. (NASDAQ:CME – Free Report) by 57.8% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 254,747 shares of the financial services provider’s stock after purchasing an additional 93,270 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in CME Group were worth $75,240,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Asset Dedication LLC boosted its stake in CME Group by 64.9% in the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the last quarter. Northwestern Mutual Investment Management Company LLC raised its holdings in shares of CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after acquiring an additional 37 shares in the last quarter. Rehmann Capital Advisory Group grew its position in CME Group by 4.3% in the third quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock worth $243,000 after acquiring an additional 37 shares in the last quarter. 1248 Management LLC boosted its holdings in shares of CME Group by 26.8% in the 3rd quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 38 shares in the last quarter. Finally, Sovran Advisors LLC grew its position in CME Group by 3.5% during the fourth quarter. Sovran Advisors LLC now owns 1,118 shares of the financial services provider’s stock valued at $305,000 after acquiring an additional 38 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on CME shares. JPMorgan Chase & Co. lifted their price objective on CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a report on Thursday, April 16th. Erste Group Bank cut shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Jefferies Financial Group reduced their price target on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a report on Thursday, April 9th. Barclays lowered their price target on CME Group from $343.00 to $316.00 and set an “equal weight” rating for the company in a research report on Thursday, April 23rd. Finally, Morgan Stanley cut their price objective on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research report on Thursday, April 23rd. Twelve equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $300.94.
CME Group Price Performance
Shares of NASDAQ:CME opened at $236.60 on Friday. The firm has a market cap of $85.73 billion, a price-to-earnings ratio of 20.19, a price-to-earnings-growth ratio of 2.58 and a beta of 0.25. The business has a 50-day simple moving average of $268.16 and a two-hundred day simple moving average of $284.62. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The firm’s revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.80 EPS. On average, analysts expect that CME Group Inc. will post 12.28 earnings per share for the current year.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Tuesday, June 9th were issued a $1.30 dividend. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.2%. CME Group’s dividend payout ratio (DPR) is presently 44.37%.
Insider Transactions at CME Group
In related news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William R. Shepard purchased 325 shares of the company’s stock in a transaction on Thursday, June 25th. The stock was purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Articles
- Five stocks we like better than CME Group
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
